Paclitaxel and carboplatin in neo-adjuvant and concomitant chemoradiotherapy in locally advanced head and neck squamous cell carcinoma

Tumori

Volumn 88, Issue 6, 2002, Pages 489-494

  Fornari, Gianni ^a   Artusio, Elisa ^a   Mairone, Lorenza ^a   Airoldi, Mario ^b   Bongioannini, Guido ^c   Amasio, Enrica ^d   Rosmino, Claudia ^c   Gabriele, Pietro ^c  

^a Ospedale Evangelico Valdese   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c MAURIZIANO HOSPITAL   (Italy)

^d MARIA VITTORIA HOSPITAL   (Italy)

Author keywords

Head and neck carcinoma; Paclitaxel; Radiotherapy

Indexed keywords

BROMPHENIRAMINE; CARBOPLATIN; CIPROFLOXACIN; DEXAMETHASONE; FLUCONAZOLE; PACLITAXEL;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HOSPITALIZATION; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; MALE; MOUTH CARCINOMA; MUCOSA INFLAMMATION; NECK DISSECTION; NEUROTOXICITY; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CARCINOMA; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; WEIGHT REDUCTION;

EID: 0036879925     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160208800611     Document Type: Article

References (29)

1. Department of Veteran Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med, 324: 1685-1690, 1991.
2. Pignon JP, Bourhis J, Domenge C, Designé L on behalf of the MACH-NC Collaborative Group: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet, 355: 949-955, 2000.
3. Rosenthal DI, Pistenmaa DA, Glatstein E: Oncology intelligence: a review of neoadjuvant chemotherapy for head and neck cancer: partially shrunken tumours may be both leaner and meaner. Int J Radiat Oncol Biol Phys, 28: 315-320, 1994.
4. Mantz CA, Vokes EE, Kies MS, Mittal B, Witt ME, List MA, Weichselbaum RR, Haraf DJ: Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer. Ann Oncol, 12: 343-347, 2001.
5. Airoldi M, Moro G, Orecchia R: Concomitant carboplatin and radiotherapy versus standard irradiation in advanced head and neck cancer: preliminary results of cooperative randomized trial. Ann Oncol, 5 (suppl 8): 116, 1994
6. Gabriele P, Tessa M, Ragona R, Rampino M, Ruo Redda MG, Beltramo G, Delmastro E, Airoldi M, Rotta P, Melano A, Moro G, Munoz F, Sola B, Orecchia R, Sannazzari GL: An interim analysis of phase III study on radiotherapy versus RT plus carboplatin in inoperable stage III-IV head and neck carcinoma. Head and Neck International Conference, abst 232, 1996.
7. Gabriele P, Tessa M, Ragona R, Rampino M, Ruo Redda MG, Delmastro E, Airoldi M, Rotta P, Moro G, Munoz F, Orecchia R, Sannazzari GL: An interim analysis of phase III study on radiotherapy versus RT plus carboplatin in inoperable stage III-IV head and neck carcinoma. ESTRO, 50A, Wien, 1996.
8. Orecchia R, Ragona R, Airoldi M, Gabriele P, Gribaudo S, Ruo Redda MG, Bussi M, Cavalot A, Rampino M, Sannazzari GL: Concomitant radiotherapy and daily low-dose carboplatin in locally advanced, unresectable head and neck cancer. Acta Oncol, 5: 541-545, 1995.
9. Suntharalingam M, Haas ML, Conley BA, Egorin MJ, Levy S, Sivasailam S, Herman MJ, Jacobs MC, Gray WC, Ord RA, Aisner JA, Van Echo DA: The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys, 47: 49-56, 2000.
10. Dang TP, Murphy BA, Cmelak A, Netterville J, Burkey B, Day T, Smith W, Wakefield G, Larson T, Smith M: Carboplatin and taxol as induction therapy for locally advanced carcinoma of the head and neck. Proc ASCO, 1516A, 1998.
11. Hoffmann W, Rodemann HP, Belka C, Budach W, Schmidberger H, Bochtler H, Heinrich V, Bamberg M: Paclitaxel in simultaneous radiochemotherapy of head and neck cancer: Preclinical and clinical results. Semin Oncol, 24 (suppl 2): 72-77, 1977.
12. Miller AB, Hogerstraeten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer, 47: 207-214, 1981.
13. National Cancer Institute, Common Toxicity Criteria Version 2.0, July 1, 1999.
14. Grecula JC, Smith RE, Rhoades CA, Sharma P, Agrawal A, Zhang H, Allen J, Goldman FP, Young D, Schuller DE: Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck. Cancer, 89: 2587-2596, 2000.
15. Machtay M, Rosenthal DI, Algazy KM, Aviles VM, Chalian AA, Hershock D, Neul R, Greenberg MJ, Mirza N, Weinstein GS, Weber RS: Pilot study of an organ preservation multimodality therapy for locally advanced resectable oropharyngeal carcinoma. Am J Clin Oncol, 23: 509-515, 2000.
16. Gray J, Meluch A, Greco F, Burris III H, Erland J, McClurkan S, Yost K, Bradof J, Hainsworth J: Induction paclitaxel/carboplatin/5FU followed by concurrent radiotherapy and weekly paclitaxel/carboplatin for patients with locally advanced head and neck cancer: a Minnie Pearl Cancer Research Network trial. Proc ASCO, 20: 226 (abst 900), 2001.
17. Colevas AD, Busse PM, Norris CM, Fried M, Tishler RB, Poulin M, Fabian RL, Fitzgerald TJ, Dreyfuss A, Peters ES, Adak S, Costello R, Barton JJ, Posner MR: Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial. J Clin Oncol, 16: 1331-1339, 1998.
18. Kies MS, Haraf DJ, Athanasiadis I, Kozloff M, Mittal B, Pelzer H, Rademaker AW, Wenig B, Weichselbaum RR, Vokes EE: Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival. J Clin Oncol, 16: 2715-2721, 1998.
19. ICRU report 62: Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50), Bethesda, USA, 1999.
20. Merlano M, Benasso M, Corvo R, Rosso R, Vitale V, Blengio F, Numico G, Margarino G, Bonelli L, Santi L: Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst, 88: 583-589, 1996.
21. Brockstein B, Haraf DJ, Stenson K, Fasanmade A, Stupp R, Glisson B, Lippman SM, Ratain MJ, Sulzen L, Klepsch A, Weichselbaum RR, Vokes EE: Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck. J Clin Oncol, 16: 735-744, 1998.
22. Forastiere AA, Berkey B, Maor M, Weber R, Goepfert H, Morrison WH, Glisson BS, Trotti A, Ridge JA, Chao C, Peters G, Lee D, Leaf A, Ensley J: Phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone, Intergroup trial R91 - 11. Proc ASCO, 20: 4A, 2001.
23. Licitra L, Grandi C, Cavina R, Guzzo M, Mariani L, Lo Vullo S, Quattrone P, Cantù G, Gardani G, Valvo F, Molinari R, Valagussa P, Bonadonna G: Primary chemotherapy (pCT) for patients with operable oral cavity cancer: results of a randomized trial. Proc ASCO, 20: 890A, 2001.
24. Urba SG, Wolf GT, Bradford CR, Thornton AF, Eisbruch A, Terrell JE, Carpenter V, Miller T, Tang G, Strawderman M: Neoadjuvant therapy for organ preservation in head and neck cancer. Laryngoscope, 110: 2074-2080, 2000.
25. Domenge C, Hill C, Lefebvre JL, De Raucourt D, Rhein B, Wibault P, Marandas P, Coche-Dequeant B, StromboniLuboinski M, Sancho-Garnier H, Luboinski B; French Groupe d'Etude des Tumeurs de la Tete et du Cou (GET-TEC): Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tete et du Cou (GETTEC). Br J Cancer, 83: 1594-1598, 2000.
26. Calais G, Alfonsi M, Bardet E: Randomized study comparing radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma (ARCORO). Preliminary results of the 94.01 study from the French Group of Radiation Oncology for the head and neck cancer (GORTEC). Proc ASCO, 17: 1484A, 1998.
27. Krengli M, Masini L, Gambaro G, Turri L, Loi G, Aluffi P, Pia F: Concurrent chemotherapy with carboplatin + fluorouracil and radiotherapy in advanced squamous cell head and neck carcinoma: a retrospective single institution's study. Tumori, 87: 312-316, 2001.
28. Rosmino C, Badii D, Delmastro E, Gabriele P, Artusio E, Fornari G: New combination of chemotherapy followed by concomitant radiochemotherapy for stage III and IV head and neck carcinomas: a phase I study. Tumori, 4 (suppl 1): S 153, 2001.
29. Chougule PB, Ready N, Akhtar M, Sambandam TS, Nigri P, Joyce D, Fram R, Wanebo H: Concurrent chemoradiotherapy for advanced inoperable head and neck cancer: a three year follow-up. Proc ASCO, 20: 927A, 2001.